Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

BACKGROUND: Assessment of the safety and efficacy of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is investigation of the efficacy of the vaccines against emerging SARS-CoV-2 variants of concern, including the B.1.351 (50...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhi, Shabir A., Baillie, Vicky, Cutland, Clare L., Voysey, Merryn, Koen, Anthonet L., Fairlie, Lee, Padayachee, Sherman D., Dheda, Keertan, Barnabas, Shaun L., Bhorat, Qasim E., Briner, Carmen, Kwatra, Gaurav, Ahmed, Khatija, Aley, Parvinder, Bhikha, Sutika, Bhiman, Jinal N., Bhorat, As’ad E., du Plessis, Jeanine, Esmail, Aliasgar, Groenewald, Marisa, Horne, Elizea, Hwa, Shi-Hsia, Jose, Aylin, Lambe, Teresa, Laubscher, Matt, Malahleha, Mookho, Masenya, Masebole, Masilela, Mduduzi, McKenzie, Shakeel, Molapo, Kgaogelo, Moultrie, Andrew, Oelofse, Suzette, Patel, Faeezah, Pillay, Sureshnee, Rhead, Sarah, Rodel, Hylton, Rossouw, Lindie, Taoushanis, Carol, Tegally, Houriiyah, Thombrayil, Asha, van Eck, Samuel, Wibmer, Constantinos K., Durham, Nicholas M., Kelly, Elizabeth J., Villafana, Tonya L., Gilbert, Sarah, Pollard, Andrew J., de Oliveira, Tulio, Moore, Penny L., Sigal, Alex, Izu, Alane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993410/
https://www.ncbi.nlm.nih.gov/pubmed/33725432
http://dx.doi.org/10.1056/NEJMoa2102214

Ejemplares similares

Ejemplares similares